share_log

大摩:重申药明康德“增持”评级 业绩及指引显示价值重估可实现

Morgan Stanley: Reiterates WUXI APPTEC 'Shareholding' rating, performance and guidance show that value re-evaluation is achievable.

Breakings ·  Mar 18 04:39

Morgan Stanley indicated that WUXI APPTEC's full-year and fourth-quarter revenue and adjusted Net income margin met the bank's expectations last year, and the guidance for this year also aligns with expectations, with further improvement in Net income margin on a high base. The bank stated that the company's Business is accelerating this year, supported by a 47% year-on-year increase in Orders last year. The company is increasing capital expenditure to expand Global capacity, and the free cash flow situation remains healthy. The bank believes that WUXI APPTEC's performance and guidance strengthen confidence in its sustained strong fundamentals and believes that the stock's value re-evaluation is achievable, reiterating the 'Shareholding' rating and a Target Price of HKD 74.3.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Comment Comment · Views 329

Recommended

Write a comment

Statement

This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.